KELLI RISER: Open Payments
NPI 1891091062 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 12 payments from 8 companies in 2025. Trend: 2023 $486 · 2024 $118 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $126 |
| Lilly USA, LLC | 3 | $53 |
| ABBVIE INC. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| PFIZER INC. | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Novo Nordisk Inc | 1 | $13 |
Products named: CAPLYTA, MOUNJARO, XIFAXAN, QULIPTA, PREVNAR 20, Omnipod, JARDIANCE, VRAYLAR.
Industry payments across OH — which companies pay providers there.
